iqukikofor.wordpress.com
The money was granted in collaboratioj withthe U.S. Army Medicall Research and Materiel Command and the throughthe Ft. Detrickm Technology Transfer Initiative. The purpose of the technology transferf program is to raise awarenesz of new and developing technologies and fundint them to transition as viables projectsfor follow-on funding in the markety place. Each company that received funding was awardedapproximately $50,0090 between March 2008 and May 2009, making up the initiative’se second round of financial awardds since its $750,000 program The funds for the program’s second phass were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. Bartlett, R-Md. “The [Ft.
Detricik Technology Transfer Initiative] program is enablinyg area businesses to harness the technologiesx being developed at Fort Detric k and apply them to thecommercial sector,” said Mikulski. “Thia will lead to new producte that have the power to created jobs andsave lives.” Mikulski announced the firstr phase of the tech transfeer program in March 2005 when 11 companiesz received funding. in The company is developing a healthg care technology calledmiTag system, which is a scalablwe wireless sensor solution for improving patient flow. in The company is developing a technology called the GeNovwa Screento identify, isolate, and producre antibody-like molecules.
in Rockville: The company is developing an on-demanx biotech products including a combinationm vaccine against plague and BioAssay Works LLCin Ijamsville: The companhy is developing a lateral-flow visual diagnostic test to detect and differentiate single samplr multiple pathogenic poxviruses, including variola, vaccinia, and monkeypox. in The company is safety-testing a medicakl product called ClotFoam, which is a non-compressible, intracavitary hemostati agent.
CynerGene IDMP in Frederick: The companuy is developing, validating and implementintg a supplemental diagnosisof HIV, and Dengue using its Infectious Disease Multiplex Panel approach, which could allow for creation of LLC in Baltimore: The company is developing required componentes and system framework to enabler conversational interfaces for telemedicine Such tools would allow professionak medics to use voice, gesture, and other human-- computer interactions to access and document information in electronic medica records.
in Rockville: The company is developing technology to preserve mammalian cells in dried format that can easilyube re-hydrated for a variety of LLC in Frederick: The companyg is evaluating the effect of Imagilin patentes probiotics as a food supplement to enhance the immune responsivenesss of guinea pigs upon immunization or challengse with virulent pathogens. The evaluation will suggest the abilityg of Imagilin patented probiotics to enhance the immunizatiom ofa vaccine. in Baltimore: The compan is developing micropatterned substratesx for viralinfectivity assays.
Juxtopia in Baltimore: The compang is customizing its Wearable Assistance and SituationalAwareneses (WASA) goggles and servicde to allow U.S. Army combat medics to access and documengt information to electrical medical recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapiesw to treat brain and spinalk cord injuries.
ليست هناك تعليقات:
إرسال تعليق